期刊文献+

3厂家复方门冬维甘滴眼液中抑菌剂的抑菌效力考察 被引量:3

Study on Preservative Effect of Compound Aspartate Dipotassium Glycyrrhetate Eye Drops from 3 Factories
原文传递
导出
摘要 目的:考察3厂家复方门冬维甘滴眼液中抑菌剂的抑菌效力。方法:采用菌落计数法,以pH7.0氯化钠-蛋白胨缓冲液为对照,测定3厂家复方门冬维甘滴眼液抑菌剂对金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、白色念珠菌及黑曲霉作用不同时间(0、7、14、28d)后的活菌数,以菌落的对数下降值为指标,评价抑菌效力。结果:3厂家复方门冬维甘滴眼液中上述各菌第7天的菌落对数下降值均在5.00~5.94范围内,第14、28天均在5.68~5.94范围内。结论:3厂家复方门冬维甘滴眼液抑菌剂的抑菌效力均符合《中国药典》标准眼用制剂要求。 OBJECTIVE: To investigte antimicrobial effects of Compound aspartate dipotassium glycyrrhetate eye drops from 3 factories. METHODS: The number of vial bacteria was determined by bacterial colony count method at different time points (0, 7, 14, 28 d) after Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger were treated with Compound aspartate dipotassium glycyrrhetate eye drops from 3 factories. Antimicrobial effects of them were evaluated using the logarithm decrease of bacteria number. RESULTS: The logarithm decrease of bacteria number of eye drops were 5.00- 5.94 on the 7th day. That of 3 kinds of preparations on 14th and 28th day were 5.68-5.94. CONCLUSION: Antimicrobial effect of Compound aspartate dipotassium glycyrrhetate eye drops from 3 factories all meet the requirements of ophthalmic preparations in Chinese Pharmacopeia.
出处 《中国药房》 CAS CSCD 2012年第13期1213-1215,共3页 China Pharmacy
关键词 复方门冬维甘滴眼液 厂家 抑菌效力 菌落计数法 Compound aspartate dipotassium glycyrrhetate eye drops Factories Antimicrobial effect Bacterial colony count method
  • 相关文献

参考文献4

二级参考文献26

  • 1刘艳,边玲.玻璃酸及卡波姆有效降低滴眼剂中防腐剂不良反应的作用[J].食品与药品,2005,7(08A):43-46. 被引量:6
  • 2凌沛学,张天民.玻璃酸钠降低滴眼剂中防腐剂不良反应的作用[J].眼科研究,2006,24(4):438-440. 被引量:19
  • 3庄越,曹宝成,萧瑞祥.实用药物制剂技术[M].北京:人民卫生出版社,1998:76.
  • 4[2]Ma X R,Su D M.Drugs microbiology examination handbook(药品微生物学检验手册)[M].Beijing:Science Press,2000:272
  • 5[3]USP29-NF24[S].2499
  • 6Sasaki H, Tei C, Yamamura K, et al. Effect of preservatives on systemic delivery of insulin by ocular instillation in rabbits[J]. JPharm Pharmacol, 1994,46( 11 ) :871.
  • 7Pisella P J, Pouliquen P, Baudouin C.Prevalence of ocular symptoms and signs with preserved and preservative free glaucom medication[J]. Br J Ophthalmol, 2002, 86 (4) : 418.
  • 8国家食品药品监督管理局.关于发布化学药物稳定性研究等16个技术指导原则的通知[EB/OL].http.//www.sda.gov.cn/WS01/CL0055/10368.html.2005-3-18.2009-2-9.
  • 9侯惠民.药用辅料应用技术[M].北京:中国医药科技出版社,2001:358,362-363.
  • 10Cha S H, Lee J S, Oum B S, et al. Corneal epithelial cellular dysfunction from benzalkoniurn chloride(BAC) in vitro [J]. Clin Experiment Ophthalmol, 2004, 32(2): 180-184.

共引文献40

同被引文献33

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部